DRUG · Mapped RxNorm record
Olaparib
Normalized identity: olaparibView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Olaparib and Durvalumab in Prostate Cancer
NCT03810105
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Durvalumab
Normalized identity: durvalumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Olaparib and Durvalumab in Prostate Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
OlaparibDRUG · verified · RxNorm: olaparib
DurvalumabDRUG · verified · RxNorm: durvalumab
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03810105 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.